- Home
- CRIS vs MBOT Comparison
CRIS vs MBOT Comparison
Compare CRIS & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- MBOT
- Stock Information
- Founded
- CRIS 2000
- MBOT 2010
- Country
- CRIS United States
- MBOT United States
- Employees
- CRIS N/A
- MBOT N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- MBOT Medical/Dental Instruments
- Sector
- CRIS Health Care
- MBOT Health Care
- Exchange
- CRIS Nasdaq
- MBOT Nasdaq
- Market Cap
- CRIS 32.8M
- MBOT 32.7M
- IPO Year
- CRIS 2000
- MBOT N/A
- Fundamental
- Price
- CRIS $3.29
- MBOT $1.64
- Analyst Decision
- CRIS Strong Buy
- MBOT Strong Buy
- Analyst Count
- CRIS 3
- MBOT 1
- Target Price
- CRIS $23.00
- MBOT $7.00
- AVG Volume (30 Days)
- CRIS 243.3K
- MBOT 6.7M
- Earning Date
- CRIS 02-06-2025
- MBOT 11-13-2024
- Dividend Yield
- CRIS N/A
- MBOT N/A
- EPS Growth
- CRIS N/A
- MBOT N/A
- EPS
- CRIS N/A
- MBOT N/A
- Revenue
- CRIS $10,259,000.00
- MBOT N/A
- Revenue This Year
- CRIS N/A
- MBOT N/A
- Revenue Next Year
- CRIS N/A
- MBOT N/A
- P/E Ratio
- CRIS N/A
- MBOT N/A
- Revenue Growth
- CRIS 0.44
- MBOT N/A
- 52 Week Low
- CRIS $2.86
- MBOT $0.82
- 52 Week High
- CRIS $17.49
- MBOT $3.38
- Technical
- Relative Strength Index (RSI)
- CRIS 44.97
- MBOT 52.97
- Support Level
- CRIS $3.10
- MBOT $1.44
- Resistance Level
- CRIS $3.60
- MBOT $1.91
- Average True Range (ATR)
- CRIS 0.37
- MBOT 0.41
- MACD
- CRIS 0.00
- MBOT -0.02
- Stochastic Oscillator
- CRIS 26.22
- MBOT 25.96
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.